Journal article
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A Hawley, Morgan D Fullerton, Fiona A Ross, Jonathan D Schertzer, Cyrille Chevtzoff, Katherine J Walker, Mark W Peggie, Darya Zibrova, Kevin A Green, Kirsty J Mustard, Bruce E Kemp, Kei Sakamoto, Gregory R Steinberg, D Grahame Hardie
Science | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2012
Grants
Awarded by Wellcome Trust
Awarded by Medical Research Council
Funding Acknowledgements
D.G.H. was supported by a Programme Grant (080982) from the Wellcome Trust and K.S. by the Medical Research Council. D.G.H. and K.S. were also funded by the companies (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Serono, and Pfizer) supporting the Division of Signal Transduction Therapy, Univ. of Dundee. The studies were also supported by grants and fellowship from the Canadian Institutes of Health Research (CIHR) (M.D.F. and G.R.S.), the Canadian Diabetes Association (J.D.S. and G.R.S.), the National Health and Medical Research Council of Australia (G.R.S. and B.E.K.), and the Australian Research Council and the Victorian Government's Operational Infrastructure Support Program (B.E.K.). J.D.S. is a DeGroote Academic Fellow (McMaster Univ.), and M.D.F. a Banting Postdoctoral Fellow (CIHR). G.R.S. is a Canada Research Chair in Metabolism and Obesity.